Alpha 2.0
Login Register
» Authors » Pascale Exer

Pascale Exer

Explore the profile of Pascale Exer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 372
Followers 0
Related Specialties
Rheumatology
General Medicine
Science
Top 10 Co-Authors
Adrian Ciurea
Almut Scherer
Michael J Nissen
Raphael Micheroli
Burkhard Moller
Kristina Burki
Giorgio Tamborrini
Jurg Bernhard
Ulrich Weber
Michael Andor
Published In
RMD Open
Arthritis Res Ther
Ann Rheum Dis
Clin Rheumatol
J Rheumatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry
Ciurea A, Gotschi A, Bram R, Burki K, Exer P, Andor M, et al.
RMD Open . 2023 Dec; 9(4). PMID: 38053462
Objective: To characterise the population fulfilling the Assessment of SpondyloArthritis international Society (ASAS) consensus definition of early axial spondyloarthritis (axSpA) and to determine the effectiveness of a first tumour necrosis...
2.
Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years
Ensslin C, Micheroli R, Kissling S, Gotschi A, Burki K, Bram R, et al.
RMD Open . 2023 Jul; 9(3). PMID: 37507208
Objective: To investigate sex differences in spinal radiographic progression in axial spondyloarthritis (axSpA). Methods: AxSpA patients in the Swiss Clinical Quality Management cohort with available spinal radiographs every 2 years...
3.
Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry
Micheroli R, Kissling S, Burki K, Moller B, Finckh A, Nissen M, et al.
Clin Rheumatol . 2023 Jun; 42(9):2377-2385. PMID: 37289315
Objective: As anaemia represents a biomarker for increased radiographic damage in rheumatoid arthritis, we aimed to investigate whether it independently predicts spinal radiographic progression in axial spondyloarthritis (axSpA). Methods: AxSpA...
4.
Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry
Ciurea A, Gotschi A, Kissling S, Bernatschek A, Burki K, Exer P, et al.
RMD Open . 2023 Jun; 9(2). PMID: 37277211
Background: Within the spectrum of spondyloarthritides, axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) present with overlapping features. Axial involvement in PsA (axial PsA) is treated according to recommendations for axSpA,...
5.
Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry
Popova V, Kissling S, Micheroli R, Bram R, de Hooge M, Baraliakos X, et al.
Arthritis Res Ther . 2023 Mar; 25(1):40. PMID: 36915202
Objectives: To analyse whether time-varying treatment with tumour necrosis factor inhibitors (TNFi) in radiographic axial spondyloarthritis (r-axSpA) has a differential impact on structural damage progression on different spinal segments (cervical...
6.
HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry
Frohlich F, Micheroli R, Hebeisen M, Kissling S, Burki K, Exer P, et al.
Clin Rheumatol . 2022 Dec; 42(5):1267-1274. PMID: 36574181
Objective: To explore the impact of the human leucocyte antigen (HLA)-B27 on the effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA). Methods: A total of...
7.
Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registry
Micheroli R, Kissling S, Burki K, Exer P, Bram R, Nissen M, et al.
RMD Open . 2022 Oct; 8(2). PMID: 36270744
Objectives: To analyse the effect of tumour necrosis factor inhibitors (TNFi) on sacroiliac joint (SIJ) radiographic progression in axial spondyloarthritis (axSpA). Methods: Patients with axSpA in the Swiss Clinical Quality...
8.
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort
Ciurea A, Kissling S, Burki K, Baraliakos X, de Hooge M, Hebeisen M, et al.
RMD Open . 2022 Feb; 8(1). PMID: 35110365
Objective: To compare disease characteristics and outcomes between patients with axial spondyloarthritis with non-radiographic disease (nr-axSpA), bilateral grade 2 sacroiliitis (r22axSpA) and unilateral/bilateral grade 3-4 sacroiliitis (r3+axSpA) according to the...
9.
Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort
Neuenschwander R, Hebeisen M, Micheroli R, Burki K, Exer P, Niedermann K, et al.
Arthritis Res Ther . 2020 Oct; 22(1):233. PMID: 33036663
Background: Sex differences with regard to clinical manifestations and response to tumor necrosis factor inhibitors (TNFi) have been delineated for the radiographic form of axial spondyloarthritis (axSpA). More limited evidence...
10.
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort
Micheroli R, Tellenbach C, Scherer A, Burki K, Niederman K, Nissen M, et al.
Ann Rheum Dis . 2020 Jun; 79(9):1203-1209. PMID: 32581090
Objective: To compare effectiveness of treatment with secukinumab (SEC) with that of alternative tumour necrosis factor inhibitors (TNFis) in patients with axial spondyloarthritis (axSpA) after withdrawal from one or more ...